Shanghai Shyndec Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 9,719.16 million compared to CNY 10,710.17 million a year ago. Revenue was CNY 9,719.16 million compared to CNY 10,710.17 million a year ago.

Net income was CNY 426.37 million compared to CNY 631.45 million a year ago. Basic earnings per share from continuing operations was CNY 0.4152 compared to CNY 0.6149 a year ago. Diluted earnings per share from continuing operations was CNY 0.3697 compared to CNY 0.535 a year ago.